Chris Nevala-Plagemann

<i>KRAS</i> Mutation Status and Treatment Outcomes in Patients With Metastatic Pancreatic Adenocarcinoma

Carter Norton, Matthew Shaw, Zachary Rubnitz et al. · JAMA Network Open · 2025 · 34 citations · Full text

Medicine, Molecular Medicine, Oncology +17

Clinical Activity of Selitrectinib in a Patient With Mammary Analogue Secretory Carcinoma of the Parotid Gland With Secondary Resistance to Entrectinib

Vaia Florou, Chris Nevala-Plagemann, Jonathan Whisenant et al. · Journal of the National Comprehensive Cancer Network · 2021 · 30 citations · Full text

Medicine, Oncology, Pharmacology +17

Real-World Outcomes of Patients With BRAF-Mutated Metastatic Colorectal Cancer Treated in the United States

Andrew D. Trunk, Matthew Braithwaite, Chris Nevala-Plagemann et al. · Journal of the National Comprehensive Cancer Network · 2022 · 23 citations · Full text

Medicine, Oncology, Chemotherapy +16

Comparative Genomic Analysis of Pancreatic Acinar Cell Carcinoma (PACC) and Pancreatic Ductal Adenocarcinoma (PDAC) Unveils New Actionable Genomic Aberrations in PACC

Vaia Florou, Andrew Elliott, Matthew H. Bailey et al. · Clinical Cancer Research · 2023 · 22 citations

Medicine, Molecular Genetics, Oncology +17

A Real-World Comparison of Regorafenib and Trifluridine/Tipiracil in Refractory Metastatic Colorectal Cancer in the United States

Chris Nevala-Plagemann, Shashank Sama, Jian Ying et al. · Journal of the National Comprehensive Cancer Network · 2023 · 17 citations · Full text

Medicine, Oncology, Pharmacotherapy +14